Markets:

Overview

News

Currencies

International

Treasuries

Novo Nordisk A/S B (OP:NONOF)

62.50 +6.33 (+11.27%)

Streaming Delayed Price Updated: 3:59 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novo Nordisk A/S B

Novo Nordisk's Wegovy Demonstrates Greater Weight Loss In Women With Heart Condition ↗

June 24, 2024

The greater weight loss in women did not result in significantly better improvements in heart failure symptoms.

Via Benzinga

Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss ↗

June 21, 2024

As per the official press release, the 16-week trial aimed to evaluate the safety, tolerability, and clinical effects of the drug called petrelintide.

Via Benzinga

The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash ↗

June 07, 2024

Dividend stocks have a record of stability and growth. Read here about three picks that are thriving and hiking dividends amid uncertainty.

Via InvestorPlace

Novo Nordisk's Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To Woo Insurers And Governments ↗

May 14, 2024

The data could potentially bolster Novo's case for Wegovy as it attempts to convince insurers and governments to cover the cost of the drug.

Via Benzinga

7 Mutual Funds That Will Outperform in Any Market ↗

February 03, 2024

While we’d all love to think we’re market geniuses, we could use the active management of outperforming mutual funds.

Via InvestorPlace

Did Ozempic Play A Role In A Man's Suicide? Family Seeks Warning Label ↗

September 11, 2023

Via Benzinga

Emmanuel Macron To Unveil Novo Nordisk Record $2.3B Investment In France's Health Sector ↗

November 23, 2023

This initiative has been touted as the biggest investment in the health sector ever made during Macron's tenure.

Via Benzinga

Experts Weigh In On Ozempic's Evolving Side Effects And How To Handle Them ↗

October 09, 2023

Via Benzinga

Diabetes Drug Ozempic May Hold Key to Breaking Addictions: The Guardian ↗

July 03, 2023

Via Benzinga

Icannex Taps Ex Pfizer, FDA & Regulatory Affairs Expert ↗

August 17, 2022

Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) appointed pharmaceutical executive Robert B. Clark to the board of directors.

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.